{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:10:18Z","timestamp":1784002218428,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Fibulin-1 is an extracellular matrix protein expressed at high levels in the placenta. Elevated circulating fibulin-1 have been observed in women with severe pre-eclampsia, whereas low levels have been found in the fetal membranes, prior to membrane rupture. The aim of the study was primarily to evaluate plasma fibulin-1 during expected normal pregnancy and delivery, and secondarily to explore fibulin-1 levels in women developing pre-eclampsia or preterm premature rupture of fetal membranes (PPROM).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From the historical longitudinal cohort originally consisting of 801 healthy Danish women with a singleton pregnancy, 128 women (632 samples) were selected. Of these, 107 women had normal pregnancies, nine experienced PPROM, and 12 pre-eclampsia. All samples were analyzed for fibulin-1, and levels were compared with blood donors. Differences in mean fibulin-1 between groups were estimated using a linear mixed model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean concentration of fibulin-1 in 120 blood donors was 15.7\u00a0\u00b5g\/mL, (25th-75th-percentiles, 12.3\u201318.2), with no significant difference in groups stratified by gender or age. Compared to baseline levels in week 12\u201320, fibulin-1 levels increased significantly from week 29\u201334 (estimated difference, 5.6\u00a0\u00b5g\/mL; standard error, 1.7;<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and 35\u201342 (12.5\u00a0\u00b5g\/mL; 1.6;<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and normalized after birth. The decrease at delivery tended to be more pronounced after elective (-7.0\u00a0\u00b5g\/mL; 2.3;<jats:italic>p<\/jats:italic>\u2009=\u20090.002) and emergency (-5.6\u00a0\u00b5g\/mL; 2.9;<jats:italic>p<\/jats:italic>\u2009=\u20090.05) cesarean section than after vaginal delivery (reference\u00a0group). Women who developed PPROM had lower fibulin-1 levels throughout their pregnancies (-11.6\u00a0\u00b5g\/mL; 4.2;<jats:italic>p<\/jats:italic>\u2009=\u20090.006). We did not observe a correlate between late pre-eclampsia and fibulin-1 (-0.2\u00a0\u00b5g\/mL; 3.0;<jats:italic>p<\/jats:italic>\u2009=\u20090.9).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Fibulin-1 was above non-pregnant levels at week 12 and increased significantly throughout pregnancy. We observed an association between low levels of fibulin-1 and PPROM. Further studies are needed to examine if fibulin-1 could serve as biomarker for the risk of PPROM. However, its role in late preeclampsia is doubtful.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>The study was conducted in accordance with the Declaration of Helsinki. The participants provided written informed consent, including storage for future use. The study was approved on July 18, 2005 by The Danish National Committee on Bioethics (No. KA 05065 and S-20,090,061) and the Danish Data Protection Agency.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12884-021-04110-y","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T08:09:53Z","timestamp":1631866193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Plasma fibulin-1 levels during pregnancy and delivery: a longitudinal observational study"],"prefix":"10.1186","volume":"21","author":[{"given":"Astrid Bakke","family":"Orvik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malene Rohr","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen","family":"Stender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pal Bela","family":"Szecsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"issue":"16","key":"4110_CR1","doi-asserted-by":"publisher","first-page":"11805","DOI":"10.1074\/jbc.M611029200","volume":"282","author":"N Kobayashi","year":"2007","unstructured":"Kobayashi N, Kostka G, Garbe JH, Keene DR, Bachinger HP, Hanisch FG, et al. A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization. J Biol Chem. 2007;282(16):11805\u201316.","journal-title":"J Biol Chem"},{"issue":"4","key":"4110_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/43.4.7534784","volume":"43","author":"EF Roark","year":"1995","unstructured":"Roark EF, Keene DR, Haudenschild CC, Godyna S, Little CD, Argraves WS. The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. J Histochem Cytochem. 1995;43(4):401\u201311.","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"4110_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF02331415","volume":"28","author":"N Miosge","year":"1996","unstructured":"Miosge N, Gotz W, Sasaki T, Chu ML, Timpl R, Herken R. The extracellular matrix proteins fibulin-1 and fibulin-2 in the early human embryo. Histochem J. 1996;28(2):109\u201316.","journal-title":"Histochem J"},{"issue":"6220","key":"4110_CR4","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.","journal-title":"Science"},{"issue":"12","key":"4110_CR5","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/sj.embor.7400033","volume":"4","author":"WS Argraves","year":"2003","unstructured":"Argraves WS, Greene LM, Cooley MA, Gallagher WM. Fibulins: physiological and disease perspectives. EMBO Rep. 2003;4(12):1127\u201331.","journal-title":"EMBO Rep"},{"issue":"1","key":"4110_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/bdrc.20003","volume":"72","author":"ML Chu","year":"2004","unstructured":"Chu ML, Tsuda T. Fibulins in development and heritable disease. Birth Defects Res C Embryo Today. 2004;72(1):25\u201336.","journal-title":"Birth Defects Res C Embryo Today"},{"key":"4110_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2840-12-6","volume":"12","author":"A Scholze","year":"2013","unstructured":"Scholze A, Bladbjerg EM, Sidelmann JJ, Diederichsen AC, Mickley H, Nybo M, et al. Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes. Cardiovasc Diabetol. 2013;12:6.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"4110_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40618-018-0891-3","volume":"42","author":"E Scarinci","year":"2019","unstructured":"Scarinci E, Tropea A, Russo G, Notaristefano G, Messana C, Alesiani O, et al. Increased fibulin-1 plasma levels in polycystic ovary syndrome (PCOS) patients: possible contribution to the link between PCOS and cardiovascular risk. J Endocrinol Invest. 2019;42(1):91\u20136.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"4110_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.placenta.2010.11.007","volume":"32","author":"C Liu","year":"2011","unstructured":"Liu C, Zhang N, Yu H, Chen Y, Liang Y, Deng H, et al. Proteomic analysis of human serum for finding pathogenic factors and potential biomarkers in preeclampsia. Placenta. 2011;32(2):168\u201374.","journal-title":"Placenta"},{"issue":"4","key":"4110_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.placenta.2009.01.007","volume":"30","author":"RM Moore","year":"2009","unstructured":"Moore RM, Redline RW, Kumar D, Mercer BM, Mansour JM, Yohannes E, et al. Differential expression of fibulin family proteins in the para-cervical weak zone and other areas of human fetal membranes. Placenta. 2009;30(4):335\u201341.","journal-title":"Placenta"},{"key":"4110_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.placenta.2016.03.015","volume":"42","author":"D Kumar","year":"2016","unstructured":"Kumar D, Moore RM, Mercer BM, Mansour JM, Redline RW, Moore JJ. The physiology of fetal membrane weakening and rupture: Insights gained from the determination of physical properties revisited. Placenta. 2016;42:59\u201373.","journal-title":"Placenta"},{"issue":"Suppl 1","key":"4110_CR12","first-page":"S121-7","volume":"144","author":"EM Joyce","year":"2009","unstructured":"Joyce EM, Moore JJ, Sacks MS. Biomechanics of the fetal membrane prior to mechanical failure: review and implications. Eur J Obstet Gynecol Reprod Biol. 2009;144 Suppl 1:S121-7.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"4110_CR13","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1160\/TH09-10-0704","volume":"103","author":"PB Szecsi","year":"2010","unstructured":"Szecsi PB, Jorgensen M, Klajnbard A, Andersen MR, Colov NP, Stender S. Haemostatic reference intervals in pregnancy. Thromb Haemost. 2010;103(4):718\u201327.","journal-title":"Thromb Haemost"},{"issue":"4","key":"4110_CR14","doi-asserted-by":"publisher","first-page":"e0231657","DOI":"10.1371\/journal.pone.0231657","volume":"15","author":"AB Orvik","year":"2020","unstructured":"Orvik AB, Andersen MR, Bratholm PS, Hedengran KK, Ritz C, Stender S, et al. Variation in plasma 25-hydroxyvitamin D2 and D3 in normal pregnancy with gestational age, sampling season, and complications: A longitudinal cohort study. PLoS One. 2020;15(4):e0231657.","journal-title":"PLoS One"},{"issue":"2","key":"4110_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1515\/CCLM.2010.033","volume":"48","author":"A Klajnbard","year":"2010","unstructured":"Klajnbard A, Szecsi PB, Colov NP, Andersen MR, Jorgensen M, Bjorngaard B, et al. Laboratory reference intervals during pregnancy, delivery and the early postpartum period. Clin Chem Lab Med. 2010;48(2):237\u201348.","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"4110_CR16","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3109\/14767058.2015.1052396","volume":"29","author":"KK Hedengran","year":"2016","unstructured":"Hedengran KK, Nelson D, Andersen MR, Stender S, Szecsi PB. Hepcidin levels are low during pregnancy and increase around delivery in women without iron deficiency - a prospective cohort study. J Matern Fetal Neonatal Med. 2016;29(9):1506\u20138.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"11","key":"4110_CR17","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/aogs.13419","volume":"97","author":"KK Hedengran","year":"2018","unstructured":"Hedengran KK, Andersen MR, Szecsi PB, Lindh C, Uldbjerg N, Stender S. Environmental tobacco smoke exposure during pregnancy has limited effect on infant birthweight and umbilical vein endothelial nitric oxide synthase. Acta Obstet Gynecol Scand. 2018;97(11):1309\u201316.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"4110_CR18","doi-asserted-by":"publisher","first-page":"3561675","DOI":"10.1155\/2016\/3561675","volume":"2016","author":"KK Hedengran","year":"2016","unstructured":"Hedengran KK, Andersen MR, Stender S, Szecsi PB. Large D-Dimer Fluctuation in Normal Pregnancy: A Longitudinal Cohort Study of 4,117 Samples from 714 Healthy Danish Women. Obstet Gynecol Int. 2016;2016:3561675.","journal-title":"Obstet Gynecol Int"},{"issue":"12","key":"4110_CR19","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.clinbiochem.2013.05.046","volume":"46","author":"L Pedersen","year":"2013","unstructured":"Pedersen L, Pedersen SM, Brasen CL, Rasmussen LM. Soluble serum Klotho levels in healthy subjects. Comparison of two different immunoassays. Clin Biochem. 2013;46(12):1079\u201383.","journal-title":"Clin Biochem"},{"key":"4110_CR20","volume-title":"R: A Language and Environment for Statistical Computing","author":"RC Team","year":"2018","unstructured":"Team RC. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2018."},{"issue":"3","key":"4110_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/mrd.20079","volume":"68","author":"B Haendler","year":"2004","unstructured":"Haendler B, Yamanouchi H, Lessey BA, Chwalisz K, Hess-Stumpp H. Cycle-dependent endometrial expression and hormonal regulation of the fibulin-1 gene. Mol Reprod Dev. 2004;68(3):279\u201387.","journal-title":"Mol Reprod Dev"},{"issue":"6","key":"4110_CR22","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/humrep\/deh841","volume":"20","author":"T Nakamoto","year":"2005","unstructured":"Nakamoto T, Okada H, Nakajima T, Ikuta A, Yasuda K, Kanzaki H. Progesterone induces the fibulin-1 expression in human endometrial stromal cells. Hum Reprod. 2005;20(6):1447\u201355.","journal-title":"Hum Reprod"},{"issue":"11","key":"4110_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/molehr\/gag078","volume":"9","author":"KS Rehman","year":"2003","unstructured":"Rehman KS, Yin S, Mayhew BA, Word RA, Rainey WE. Human myometrial adaptation to pregnancy: cDNA microarray gene expression profiling of myometrium from non-pregnant and pregnant women. Mol Hum Reprod. 2003;9(11):681\u2013700.","journal-title":"Mol Hum Reprod"},{"issue":"7","key":"4110_CR24","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1182\/blood.V88.7.2569.bloodjournal8872569","volume":"88","author":"S Godyna","year":"1996","unstructured":"Godyna S, Diaz-Ricart M, Argraves WS. Fibulin-1 mediates platelet adhesion via a bridge of fibrinogen. Blood. 1996;88(7):2569\u201377.","journal-title":"Blood"},{"issue":"33","key":"4110_CR25","doi-asserted-by":"publisher","first-page":"19458","DOI":"10.1074\/jbc.270.33.19458","volume":"270","author":"H Tran","year":"1995","unstructured":"Tran H, Tanaka A, Litvinovich SV, Medved LV, Haudenschild CC, Argraves WS. The interaction of fibulin-1 with fibrinogen. A potential role in hemostasis and thrombosis. J Biol Chem. 1995;270(33):19458\u201364.","journal-title":"J Biol Chem"},{"issue":"4","key":"4110_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bcp.2015.04.012","volume":"95","author":"DA Shah","year":"2015","unstructured":"Shah DA, Khalil RA. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochem Pharmacol. 2015;95(4):211\u201326.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"4110_CR27","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1111\/1471-0528.15042","volume":"125","author":"AS Cerdeira","year":"2018","unstructured":"Cerdeira AS, Agrawal S, Staff AC, Redman CW, Vatish M. Angiogenic factors: potential to change clinical practice in pre-eclampsia? BJOG. 2018;125(11):1389\u201395.","journal-title":"BJOG"},{"issue":"1","key":"4110_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1067\/mob.2003.115","volume":"188","author":"T Lee","year":"2003","unstructured":"Lee T, Carpenter MW, Heber WW, Silver HM. Preterm premature rupture of membranes: risks of recurrent complications in the next pregnancy among a population-based sample of gravid women. Am J Obstet Gynecol. 2003;188(1):209\u201313.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"4110_CR29","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/jog.12392","volume":"40","author":"H Okada","year":"2014","unstructured":"Okada H, Tsuzuki T, Shindoh H, Nishigaki A, Yasuda K, Kanzaki H. Regulation of decidualization and angiogenesis in the human endometrium: mini review. J Obstet Gynaecol Res. 2014;40(5):1180\u20137.","journal-title":"J Obstet Gynaecol Res"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-04110-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T23:24:12Z","timestamp":1699485852000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-04110-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4110"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-04110-y","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"assertion":[{"value":"30 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The participants provided written informed consent, including storage for future use. The study was approved on July 18, 2005 by the The Danish National Committee on Bioethics (No. KA 05065) and (S-20090061) and the Danish Data Protection Agency.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors has any financial or other actual or potential conflicts of interest capable of influencing any part of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"629"}}